Granules India Ltd - 532482 - Outcome of Board Meeting
Outcome of 195th Board Meeting dated 22nd October 201922-10-2019
22-10-2019
Granules India Ltd - 532482 - Outcome Of 195Th Board Meeting Dated 22Nd October 2019.
Outcome of 195th Board Meeting dated 22nd October 2019.22-10-2019
Granules India Ltd - 532482 - Granules India Limited Received US FDA Approval For Fexofenadine Hydrochloride Tablets
Granules India Limited received US FDA approval for Fexofenadine Hydrochloride Tablets21-10-2019
GRANULES INDIA LTD.-$ - 532482 - Granules India Limited Received US FDA Approval For Fexofenadine Hydrochloride Tablets
Granules India Limited received US FDA approval for Fexofenadine Hydrochloride Tablets21-10-2019
Granules India Ltd - 532482 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 010100 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer16-10-2019
Granules India Ltd - 532482 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and disclosure requirements) Regulations, 2015.16-10-2019
Granules India Ltd - 532482 - Submission Of Certificate Under Regulation 40 (9) Of SEBI (LODR) Of Regulations, 2015.
Submission of Certificate under regulation 40 (9) of SEBI (LODR) of Regulations, 2015.16-10-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Earnings Conference call for Q2, FY 2019-20.15-10-2019
Granules India to exit from China jt venture
Granules India Ltd (GIL), today announced its intention to divest its entire equity shareholding in Granules Biocause Pharmaceuticals Co. Ltd. by se14-10-2019
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results For The Second Quarter Ended September 30, 2019 And The Payment Of Second Interim Dividend For The FY 2019-20 If Any.
GRANULES INDIA LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2019 ,inter alia, to consider and approve To consider and approve the Un-audited Financial Results for the second quarter ended September 30, 2019 and the payment of second interim dividend for the FY 2019-20 if any.14-10-2019